SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: IRWIN JAMES FRANKEL who wrote (4965)7/16/2001 9:10:12 AM
From: Doc Bones  Respond to of 10280
 
I'm renaming it ESNORRA <eom>



To: IRWIN JAMES FRANKEL who wrote (4965)7/16/2001 10:14:07 AM
From: Harold Engstrom  Read Replies (1) | Respond to of 10280
 
More good news. This can't be good for the stock price.

Doc, you need to go into the name consulting business. <g>

H



To: IRWIN JAMES FRANKEL who wrote (4965)7/17/2001 1:34:55 PM
From: quidditch  Respond to of 10280
 
Message 16085587

The message following the url, summarizing the cc, contains references to zopiclone.

quid



To: IRWIN JAMES FRANKEL who wrote (4965)8/16/2001 12:05:33 AM
From: rjm2  Read Replies (1) | Respond to of 10280
 
S)-zopiclone

Is this the same as the zopliclone that is sold overseas ? Or has it been suped up ?

For me, it leaves me groggy the next day as does Ambien & melatonin. Zopiclone also leaves a metallic taste in my mouth the next morning.

I dont expect its a lot better than the others out there.But there are probably enough insomniacs out there to support it.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News